Humanigenincis A Clinical Stage Biopharmaceutical Company Based In Burlingamecaliforniawith A Focus On Developing Monoclonal Antibody Therapies For Immuno Oncology And Immunomodulationfounded In 2000The Company Utilizes Its Proprietary Humaneeredatechnology To Create Humanized Antibodies From Mouse Derived Antibodiesenhancing Their Therapeutic Potential For Various Inflammatory Conditions The Company S Core Areas Include Immuno Oncologytargeting Solid Tumors And Hematologic Malignanciesand Immunomodulationaddressing Issues Like Cytokine Storms And Autoimmune Disorderskey Products In Their Pipeline Include Lenzilumabwhich Has Applications In Covid 19 And Car T Therapyifabotuzumab For Solid Tumorsand Hgen005 For Inflammatory And Oncologic Indicationshumanigen Collaborates With Institutions Like The Nih To Advance Its Research And Development Efforts
